Doloresz Katanich
Business
Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%
Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.
Markets
Personal finance and AI: Should you trust ChatGPT’s investment advice?
Retail investors keep flocking to publicly-available online AI tools such as ChatGPT to help with their financial decisions, despite clear warnings about risks. But how capable are simple AI models of providing reliable and trustworthy investment advice?